Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Antipruritics dermatologic use of)
116 results
  • Insights into future therapeutics for atopic dermatitis. [Review]
  • EOExpert Opin Pharmacother 2018; 19(3):265-278
  • Edwards T, Patel NU, … Strowd LC
  • Atopic Dermatitis (AD) is a common chronic inflammatory skin disorder with a constellation of symptoms. Currently, there are numerous therapies in various phases of drug development that target the p...
  • What's eating you? chiggers. [Journal Article]
  • CCutis 2017; 99(6):386-388
  • Hohenberger ME, Elston DM
  • Belonging to the Trombiculidae family of mites, chigger specifically refers to the larval stage of the mite's life cycle when it is able to bite its host. Although humans act as an accidental host, c...
  • [Pruritus of the scalp : Simply pulling out your hair?] [Review]
  • HHautarzt 2017; 68(6):449-456
  • Beigi M, Weisshaar E
  • Scalp pruritus is a frequent symptom and can be caused by dermatologic diseases, contact allergies, neurologic, psychiatric/somatoform and systemic diseases. In daily clinical practice scalp pruritus...
  • Topical Botanical Agents for the Treatment of Psoriasis: A Systematic Review. [Review]
  • AJAm J Clin Dermatol 2017; 18(4):451-468
  • Farahnik B, Sharma D, … Sivamani RK
  • CONCLUSIONS: The literature addresses a large number of studies in regard to botanicals for the treatment of psoriasis. While most agents appear to be safe, further research is necessary before topical botanical agents can be consistently recommended to patients.
  • Trombiculiasis: not only a matter of animals! [Journal Article]
  • WMWien Med Wochenschr 2017; 167(3-4):70-73
  • Guarneri C, Chokoeva AA, … Tchernev G
  • Trombiculiasis represents a striking emerging infestation in humans. In fact, modified lifestyles and easy and quick traveling around the globe, together with the altered ecology and habits of the pa...
  • Drug-Induced Itch Management. [Review]
  • CPCurr Probl Dermatol 2016; 50:155-63
  • Ebata T
  • Drugs may cause itching as a concomitant symptom of drug-induced skin reactions or in the form of pruritus without skin lesions. Drug-induced itch is defined as generalized itching without skin lesio...
  • Itch Management: Topical Agents. [Review]
  • CPCurr Probl Dermatol 2016; 50:40-5
  • Metz M, Staubach P
  • Chronic pruritus is a common problem in patients with inflammatory skin diseases as well as in subjects with dry or sensitive skin. Regardless of the underlying cause of the pruritus, a topical thera...
  • Current and Emerging Therapies for Itch Management in Psoriasis. [Review]
  • AJAm J Clin Dermatol 2016; 17(6):617-624
  • Stull C, Grossman S, Yosipovitch G
  • Pruritus is a common and significant symptom among patients with psoriasis. Pruritus is often present beyond the borders of psoriatic plaques, and frequently affects the scalp and genital regions. Ps...
  • Advances in therapeutic strategies for the treatment of pruritus. [Review]
  • EOExpert Opin Pharmacother 2016; 17(5):671-87
  • Stull C, Lavery MJ, Yosipovitch G
  • CONCLUSIONS: At present, there is no universally effective treatment available for all types of chronic pruritus. A combination of topical and systemic therapies addressing peripheral mediators, and a top-down approach targeting the brain and spinal cord, seems preferable to a single agent approach. Neural hypersensitization plays a significant role in many forms of chronic pruritus and may be downregulated by new treatments. In addition, specific neuropeptides are now targeted by novel antipruritic therapies. Furthermore, targeted biologic agents are anticipated to play a significant role in treating pruritus of inflammatory origin.
New Search Next